Abstracts S562 muscular layer of the stomach and then the endoscope was advanced into the peritoneal cavity. Aft er intraperitoneal exploration, the esophageal mucosal entry was closed with endoclips. All dogs resumed food 12 hours aft er the procedures. Diets, behavior and body temperature of all dogs were observed. Endoscopic examinations were performed 4 weeks aft er the procedure, and then necropsy were executed. Results: Th e ECGT access was successfully created in all dogs. Diets, behavior and body temperature were normal in all dogs. Th e entry of esophagus was healed well in 9 dogs. Th e mucosa of the entry was torn in one dog, but the submucosal tunnel was healed well at cardia. Necropsy showed complete closure of gastric serosal exit, and no intraperitoneal abscess was found. Histopathological examinations showed submucosal tunnels healed well. Conclusion: Th e ECGT access is feasible and safe for NOTES peritoneal access. It should be a good choice for the clinical application of NOTES procedures.
Introduction: Endoscopic balloon dilatation (EBD) is the treatment of choice for intestinal short stricture in Crohn's disease (CD) . Th e use of steroid intrastricture injection (SII) aft er balloon dilatation (BD) has been reported but the safety is controversial. To investigate the short and long-term outcomes of EBD for CD strictures. Methods: Th irty-eight endoscopic BD were performed in 27 patients between 2006 and 2012 (14 women; 13 men; mean age 41 years).Th e inclusion criteria were symptomatic strictures refractory to medical treatment (20 thiopurine and 7 steroids therapy), with a length less than 5 cm (mean 2 cm); the exclusion criterion was the coexistence of a fi stulizing pattern. All dilations were performed using through-the-scope balloons; in 24 procedures, was used, a balloon of diameter greater than 15 mm; in 14 a diameter less than 15 mm. Th e mean follow-up time was 18.8 months (5-50 months). Primary success was defi ned as passage of the scope through the stricture. Long-term outcomes were analyzed focusing on intervention-free survival. Results: Th e 28 strictures (a patient had 2 de novo stenosis) included 10 anastomotic strictures (AS), 5 at the colocolic and 5 at the ileocolonic anastomosis, and 18 de novo strictures (DNS), 3 in the ileum, 4 in the sigma, 2 discendent colon, 6 in the rectum and 3 at the ileocaecal valve. Th irteen patients (46%) had active infl ammation (AI) to biopsies and received a local quadrantic injection of triamcinolone (40 mg dose ) aft er BD. Primary success was achieved in 37 of the 38 strictures (97%). Of the 38 treatments, complications occurred in 4 cases (10%) consistent with perforations. Th ere was no procedure-related mortality. Aft er a median follow-up of 12 months, re-strictures aft er EBDs occurred in 5 cases (22%). In conclusion at 1-year follow-up, 66% of the patients had undergone no further intervention (EBD or surgery) with a substantial but no signifi cative diff erence in patients treated with SII compared to those treated only with EBD (8% vs 28% p=0.163). No signifi cant diff erence between the AS and DNS in the reintervention-free survival (RFS) at 1 year follow-up (80% vs 83% p=0.825). In patients treated with the larger balloon the RFS was 70% versus 78.5% in patients treated with the smaller balloon (p=0.803). Conclusion: Th is study confi rms that EBD may be an eff ective alternative to surgical resection. SII did not prolong signifi cantly the effi cacy of BD in selected pts with AI. Th e use of a balloon greater than 15 mm is not associated with a better long term outcome.
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Th e Improvement of the Endoscopic Techniques for the Diagnosis of Celiac Disease: Proposal of an Endoscopic Classifi cation and Correlation With Histological Findings
Lorete Kotze, PhD, 1 MAURO BONATTO, MD, 2 Luiz Kotze, MD 1 . 1. Pontifi cal University of Paraná, Curitiba, Brazil; 2. GASTROCLINICA CASCAVEL LTDA, Cascavel, Brazil. Introduction: Th e purpose of this study was to evaluate the correlation between endoscopic aspects of the duodenal mucosa and histological fi ndings for the diagnosis of celiac disease (CD) and detect patients response to a gluten-free diet (GFD). Methods: Study of 34,540 patients submitted to standard upper gastrointestinal videoendoscopy (UGE) at a Brazilian gastroenterology service between January 2000 and March 2010. Among patients >14 years, 2,384 cases of duodenitis were found, 109 of which suggestive of CD (1/317 routine UGEs). Including 80 females (73.40%; mean age: 35.16 years; range: 16-58) and 29 males (26.60%; mean age: 34.10 years; range: 15-62), the selected patients were submitted to lab tests, a second UGE and histological evaluation of the duodenum by chromoscopy (indigo carmine, 115x magnifi cation, registered with an Olympus GIF-160Z). All 109 patients were confi rmed as CD by UGE, histology and serological tests. Aft er one year of GFD, only 85/109 patients (females n=64/75.30% versus males n=21/24.70%) were controlled. Our UGE and chromoscopy fi ndings were compared with the histological classifi cation of Marsh (0-4). UGE Type I: agglutinated villi not forming mosaic appearance versus Marsh 1; UGE Type II: agglutinated villi forming mosaic appearance with identifi cation of villi versus Marsh 2; UGE Type III: agglutinated villi, mosaic appearance with absence of villi versus Marsh 3 and 4. Results: At the time of diagnosis correlations were: UGE I n=5 (5.8%): Marsh 2 n=4 (80%), Marsh 3 n=1 (20%); UGE II n=25 (29.4%): Marsh 2 n=4 (16%), Marsh 3 n=21 (84%); UGE III n=66 (64.7%): Marsh 2 n=4 (7.2%), Marsh 3 n=50 (90.9%), Marsh 4 n=1 (1.8%). Aft er one year of GFD: normal UGE n=5 (5.8%): Marsh 1 n=2 (40%), Marsh 2 n=2 (40%), Marsh 3 n=1 (20%); UGE I n=44 (51.7%): Marsh 1 n=5 (11.1%), Marsh 2 n=23 (52.2%), Marsh 3 n=16 (36.3%); UGE II n=27 (31.7%): Marsh 2 n=6 (23%), Marsh 3 n=21 (77%); UGE III n=9 (10.5%); Marsh 1 n=1 (11.1%), Marsh 2 n=1 (11.1%), Marsh 3 n=7 (77%). Conclusion: Standard UGE with chromoscopy and image magnifi cation can reveal areas for biopsy, thereby contributing to the diagnosis of CD. Th e endoscopic classifi cation into types may be used in both diagnosis and control of CD patients aft er DFG. Th e endoscopy/histology correlation was stronger in advanced duodenal lesions, but may be of help in intermediate cases.
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IBD Surveillance Colonoscopies Require More Time and Medication Th an Screening Colonoscopies for Non-IBD Patients
Emilie Regner, MD, Gregory Austin, MD, MPH, Mark Gerich, MD. University of Colorado, Aurora, CO.
Introduction: To examine diff erences in procedure duration and medication use during colonoscopy with random dysplasia surveillance biopsies in IBD patients and screening colonoscopy with at least one biopsy in non-IBD controls. Methods: We conducted a retrospective review of all surveillance colonoscopies performed at our institution from January 2010 to March 2014 for patients with IBD who were less than 75 years old and had no previous bowel resection. We extracted data regarding patient demographics and disease phenotype, total procedure time and withdrawal time, medication use, quality of bowel preparation, endoscopist, and complications. Corresponding data were collected for age-, gender-and endoscopist-matched non-IBD controls undergoing screening colonoscopy with at least one biopsy. Procedures performed by fellows or for diagnostic purposes were excluded. A generalized linear model (GLM) was used to compare procedure time, withdrawal time, and medication use between groups aft er controlling for patient age, gender, and endoscopist. A GLM was used to test for main eff ects of group (IBD or non-IBD) and endoscopist as well as the group by endoscopist interaction aft er controlling for patient age, gender, and quality of bowel preparation. Results: One hundred and thirty-three IBD surveillance colonoscopy procedures were included along with 133 non-IBD screening colonoscopy controls matched for age, sex and endoscopist. Compared with screening colonoscopies for non-IBD patients, surveillance colonoscopies for IBD patients required signifi cantly longer withdrawal time (3.4 minutes; p<0.002), longer total procedure time (3.9 minutes; p<0.001), and more fentanyl (200 mcg vs. 150 mcg; p<0.003). Conclusion: Aft er controlling for other impacting factors, colonoscopy procedure time, withdrawal time, and medication use are greater for colonoscopies with random dysplasia surveillance biopsies in IBD patients than for screening colonoscopies in non-IBD patients during which a biopsy is performed. Dissimilar procedures with diff erent resource utilization should be coded and reimbursed as discrete entities.
1898
Endoscopic Classifi cation of Eosinophilic Esofagitis
Lorete Kotze, DO, FACG, Augusto Fey, MD. Pontifi cal Catholic University, Curitiba, Brazil. Introduction: Th e purpose of this study is to suggest an endoscopic classifi cation of eosinophilic esophagitis (EE) to better recognize this disease and guide biopsies for histological diagnosis. Methods: Th is study consisted in a prospective research (September 2011 to September 2013) with biopsies performed in all patients who had endoscopic fi ndings or symptoms that suggested EE, supporting an classifi cation as follow: Type 0 = Normal endoscopy with typical symptoms; Type 1 = Linear furrows or rings, with or without symptoms; Type 2 = White plaques and exudates, with or without symptoms; and Type 3 = Complicated lesions like ulcer, strictures and polyps. Results: Following this classifi cation, 133 patients were included. Twenty-four presented at least 15 eosinophils per high-power microscopic fi eld (HPMF), that was considered Group A (GA). Also, 10 cases with 5-14 eosinophils/HPMF with typical symptoms and/or endoscopic fi ndings were detected, that was considered Group B (GB). Linking the groups A and B with the endoscopic classifi cations was found: Type 0, Type 1, Type 2, Type 3, Group A 2 9 8 5, Group B 0 6 2 2. For comparison, a retrospective research on medical archives in the same endoscopic clinic was done during previous two years: only two patients with at least 15 eosinophils/HPMF were diagnosed. Conclusion: Th e fi ndings showed that an investigation based on a pre-established protocol and classifi cation can increase a lot the diagnosis of this disease. Th e question is if cases with clinical and/or endoscopic fi ndings suggesting EE and with minor than 15 eosinophils/ HPMF could be included in the diagnosis of EE.
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Yield of Capsule Endoscopy for Obscure Gastrointestinal Bleed
Chinemerem Okwara, MD, 1 Leon Kundrotas, MD, 2 Raju Akriti, MD 2 . 1. UT Southwestern Medical Center, Dallas, TX; 2. University of Texas Health and Science Center at San Antonio, San Antonio, TX.
Introduction:
To determine the detection rate of capsule endoscopy in the South Texas VA population and the location of the lesions identifi ed. Methods: Th is is a retrospective study in which we examined 200 veterans who received capsule endoscopy for either the indication of anemia or GI bleed from 2006 to 2013. Subjects who received the capsule endoscopy specifi cally for esophageal varices, malignancy screen or Crohn's disease were excluded. Results: In our study, we found a source of bleed in 21 of the 200 subjects reviewed for a detection rate of 10.5%. From the 21 subjects in which a bleeding source was found, 10/21 (48%) was due to a gastric source, 7/21 (33%) was due to a small bowel source, 2/21 (10%) was due to a colonic source and 2/21 (10%) was due to both a small bowel and gastric source. Of the subjects with identifi ed bleed (n=21), 38% (8/21) were overt obscure GI bleed and 61.9% (13/21) was occult obscure GI bleed. Th ere were 11 incomplete studies; capsule failed to reach colon in 8/200 and fails to enter small bowel in 3/200. Conclusion: In our study, our detection rate was 10.5% for all sources of bleeding and 3.5% for isolated small bowel causes of bleeding. Incompletion rate was 5.5%. Th e most common fi nding, without active bleeding identifi ed by the capsule, was angiodysplasias. Almost half of the lesions found were in the stomach, suggesting that the missed gastric lesions could have been found if a second look upper endoscopy was performed. Delivering the capsule via upper endoscopy to the small bowel can serve as a second look and decrease the incompletion rate as well. . Th e PEG site tumor has shown to be metastasizing to various organs, even aft er the removal of the primary tumor. Time of survival from the diagnosis of PEG site metastasis ranged from 1 month to 33 months. Conclusion: Th e reported rate of PEG site metastasis is 1-2% in head and neck cancer patients by the pull method. Th e proposed mechanism is direct tumor cell inoculation by trauma during PEG placement. Th ere has been some retrospective studies which have shown that the push technique is better than pull through technique to prevent this complication. Randomized studies are needed to compare the complication rate between these two techniques.
